These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
282 related articles for article (PubMed ID: 29435273)
1. Efficacy of vonoprazan for 24-week maintenance therapy of patients with healed reflux esophagitis refractory to proton pump inhibitors. Mizuno H; Yamada K; Minouchi K; Kamiyamamoto S; Hinoue Y Biomed Rep; 2018 Feb; 8(2):148-155. PubMed ID: 29435273 [TBL] [Abstract][Full Text] [Related]
2. Efficacy of Vonoprazan for 48-Week Maintenance Therapy of Patients with Healed Reflux Esophagitis. Mizuno H; Nishino M; Yamada K; Kamiyamamoto S; Hinoue Y Digestion; 2020; 101(4):411-421. PubMed ID: 31129668 [TBL] [Abstract][Full Text] [Related]
3. Efficacy of vonoprazan for initial and maintenance therapy in reflux esophagitis, nonerosive esophagitis, and proton pump inhibitor-resistant gastroesophageal reflux disease. Gotoh Y; Ishibashi E; Honda S; Nakaya T; Noguchi C; Kagawa K; Murakami K Medicine (Baltimore); 2020 Mar; 99(11):e19520. PubMed ID: 32176102 [TBL] [Abstract][Full Text] [Related]
4. A systematic review and meta-analysis of the efficacy of vonoprazan for proton pump inhibitor-resistant gastroesophageal reflux disease. Simadibrata DM; Lesmana E; Fass R J Gastroenterol Hepatol; 2024 May; 39(5):796-805. PubMed ID: 38263507 [TBL] [Abstract][Full Text] [Related]
5. Efficacy of long-term maintenance therapy with 10-mg vonoprazan for proton pump inhibitor-resistant reflux esophagitis. Tanabe T; Hoshino S; Kawami N; Hoshikawa Y; Hanada Y; Takenouchi N; Goto O; Kaise M; Iwakiri K Esophagus; 2019 Oct; 16(4):377-381. PubMed ID: 31119492 [TBL] [Abstract][Full Text] [Related]
6. The Effects of Switching to Vonoprazan, a Novel Potassium-Competitive Acid Blocker, on Gastric Acidity and Reflux Patterns in Patients with Erosive Esophagitis Refractory to Proton Pump Inhibitors. Yamashita H; Kanamori A; Kano C; Hashimura H; Matsumoto K; Tsujimae M; Yoshizaki T; Momose K; Obata D; Eguchi T; Fujita M; Okada A Digestion; 2017; 96(1):52-59. PubMed ID: 28662503 [TBL] [Abstract][Full Text] [Related]
7. A study for every second day administration of vonoprazan for maintenance treatment of erosive GERD (ESD von GERD): a multicenter randomized cross-over study. Matsuda S; Kato M; Sakakibara Y; Hamada H; Sasaki Y; Mori H; Hirai Y; Inoue S; Toyokawa T; Kagaya T; Kuwai T; Esaka N; Yamashita H; Watanabe N; Matsumoto M; Fujii H; Demura M; Kubo K; Mabe K; Harada N J Gastroenterol; 2022 Mar; 57(3):133-143. PubMed ID: 35092498 [TBL] [Abstract][Full Text] [Related]
8. Vonoprazan 10 mg daily is effective for the treatment of patients with proton pump inhibitor-resistant gastroesophageal reflux disease. Shinozaki S; Osawa H; Hayashi Y; Sakamoto H; Kobayashi Y; Lefor AK; Yamamoto H Biomed Rep; 2017 Sep; 7(3):231-235. PubMed ID: 28894571 [TBL] [Abstract][Full Text] [Related]
9. Maintenance for healed erosive esophagitis: Phase III comparison of vonoprazan with lansoprazole. Ashida K; Iwakiri K; Hiramatsu N; Sakurai Y; Hori T; Kudou K; Nishimura A; Umegaki E World J Gastroenterol; 2018 Apr; 24(14):1550-1561. PubMed ID: 29662293 [TBL] [Abstract][Full Text] [Related]
10. Factors Associated with Potassium-Competitive Acid Blocker Non-Response in Patients with Proton Pump Inhibitor-Refractory Gastroesophageal Reflux Disease. Okuyama M; Nakahara K; Iwakura N; Hasegawa T; Oyama M; Inoue A; Ishizu H; Satoh H; Fujiwara Y Digestion; 2017; 95(4):281-287. PubMed ID: 28501868 [TBL] [Abstract][Full Text] [Related]
11. Use of vonoprazan, a novel potassium-competitive acid blocker, for the treatment of proton pump inhibitor-refractory reflux esophagitis in patients with systemic sclerosis. Shirai Y; Kawami N; Iwakiri K; Kuwana M J Scleroderma Relat Disord; 2022 Feb; 7(1):57-61. PubMed ID: 35386943 [TBL] [Abstract][Full Text] [Related]
12. Efficacy of Vonoprazan, a Novel Potassium-Competitive Acid Blocker, in Patients with Proton Pump Inhibitor-Refractory Acid Reflux. Akiyama J; Hosaka H; Kuribayashi S; Moriyasu S; Hisada Y; Okubo H; Watanabe K; Imbe K; Nagata N; Kojima Y; Yokoi C; Uemura N; Shimoyama Y; Kawamura O; Yamada M; Kusano M Digestion; 2020; 101(2):174-183. PubMed ID: 30897577 [TBL] [Abstract][Full Text] [Related]